We are live on ! Find out more
PPCM

Pillar Pacific Capital Management Portfolio holdings

AUM $1.29B
1-Year Est. Return 80.18%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+80.18%
3 Year Est. Return
+84.96%
5 Year Est. Return
+177.6%
10 Year Est. Return
AUM
$866M
AUM Growth
+$28.6M
Cap. Flow
+$9.42M
Cap. Flow %
1.09%
Top 10 Hldgs %
16.38%
Holding
306
New
16
Increased
177
Reduced
70
Closed
6

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.29M
2
BAY
BAYER AG SPONS ADR
BAY
+$3.36M
3
WH icon
Wyndham Hotels & Resorts
WH
+$2.17M
4
XOM icon
ExxonMobil
XOM
+$1.32M
5
AGN
Allergan plc
AGN
+$1.22M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Financials 15.94%
3 Industrials 15.74%
4 Healthcare 12.33%
5 Consumer Discretionary 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAV
176
DELISTED
Navistar International
NAV
$509K 0.06%
12,500
NSIT icon
177
Insight Enterprises
NSIT
$3.89B
$502K 0.06%
10,250
+300
+3% +$12.9K
HOPE icon
178
Hope Bancorp
HOPE
$1.79B
$500K 0.06%
28,039
+840
+3% +$15.2K
DY icon
179
Dycom Industries
DY
$12B
$492K 0.06%
5,200
+135
+3% +$13.8K
AME icon
180
Ametek
AME
$55.4B
$487K 0.06%
6,760
+285
+4% +$21.1K
PLOW icon
181
Douglas Dynamics
PLOW
$1.02B
$486K 0.06%
10,130
+250
+3% +$11.3K
PFE icon
182
Pfizer
PFE
$143B
$482K 0.06%
13,997
FBIN icon
183
Fortune Brands Innovations
FBIN
$5.88B
$480K 0.06%
10,472
-58
-0.6% -$2.81K
DXCM icon
184
DexCom
DXCM
$32.2B
$475K 0.05%
20,000
+900
+5% +$19.1K
UTHR icon
185
United Therapeutics
UTHR
$25.8B
$467K 0.05%
4,125
+100
+2% +$11K
MEI icon
186
Methode Electronics
MEI
$496M
$457K 0.05%
11,350
+400
+4% +$16.3K
BG icon
187
Bunge Global
BG
$20.4B
$451K 0.05%
6,475
+250
+4% +$17.9K
TXN icon
188
Texas Instruments
TXN
$252B
$448K 0.05%
4,060
-42
-1% -$4.54K
GATX icon
189
GATX Corp
GATX
$6.35B
$440K 0.05%
5,925
+200
+3% +$14.1K
WGL
190
DELISTED
Wgl Holdings
WGL
$439K 0.05%
4,950
VDE icon
191
Vanguard Energy ETF
VDE
$10.1B
$437K 0.05%
4,162
+258
+7% +$26.4K
WNC icon
192
Wabash National
WNC
$512M
$435K 0.05%
23,300
+800
+4% +$16.2K
IART icon
193
Integra LifeSciences
IART
$1.29B
$433K 0.05%
6,725
+250
+4% +$15.5K
MRK.PRB
194
DELISTED
MERCK & CO INC 6% PFD CONV
MRK.PRB
$432K 0.05%
7,112
SPPI
195
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$412K 0.05%
19,650
+1,750
+10% +$32.4K
MTZ icon
196
MasTec
MTZ
$20.8B
$406K 0.05%
8,000
+275
+4% +$13.3K
SINA
197
DELISTED
Sina Corp
SINA
$405K 0.05%
4,785
+150
+3% +$14K
RBB icon
198
RBB Bancorp
RBB
$448M
$401K 0.05%
12,475
-3,125
-20% -$91.9K
PRFT
199
DELISTED
Perficient Inc
PRFT
$399K 0.05%
15,125
+525
+4% +$13.2K
PPLI
200
People Inc
PPLI
$3.09B
$396K 0.05%
14,548
+420
+3% +$11.5K

Similar funds

Pillar Pacific Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Pillar Pacific Capital Management held 306 positions worth $866M, up 3.4% from $838M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Pillar Pacific Capital Management's Q2 2018 filing shows 16 new, 177 increased, 70 reduced and 6 closed positions. Its largest new stake was NVIDIA: 706,760 shares worth $4.19M. The largest sale was Monsanto Co, an estimated $4.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

  • Pillar Pacific Capital Management's largest Q2 2018 buy was NVIDIA: 706,760 shares worth $4.19M.
  • Pillar Pacific Capital Management added most to ExxonMobil in Q2 2018, an estimated $1.32M increase.
  • Pillar Pacific Capital Management's biggest Q2 2018 reduction was Travel + Leisure Co, cutting an estimated $1.91M.
  • Pillar Pacific Capital Management fully exited Monsanto Co in Q2 2018, selling an estimated $4.9M.
  • Pillar Pacific Capital Management's ten largest holdings make up 16% of its $866M portfolio in Q2 2018.
  • Pillar Pacific Capital Management opened 16 new positions and closed 6 in Q2 2018.
  • Pillar Pacific Capital Management's portfolio value rose 3.4% quarter-over-quarter to $866M.

Based on Pillar Pacific Capital Management's 13F filing for Q2 2018, filed 7 Aug 2018.